41

Bioteque

4107 · TWO · Healthcare / Medical Instruments & Supplies

106.50TWD+0.50 (+0.47%)

Price History

Full chart

Market Stats

Previous Close106.00
Open106.50
Day Range106.50 – 107.00
52-Week Range106.85 – 125.92
Volume32.44K
Market Cap7.62B
P/E (TTM)13.00
Forward P/E23.42
EPS8.46
Dividend Yield5.00%
Beta0.12
50-Day Avg112.88
200-Day Avg117.27

About

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen masks and tubing, anesthesia mask, sprayer and spray mask, endotracheal tube, and tracheostomy tube. It also provides pig tail drainage tube assembly, pig tail drainage tube, percutaneous drainage catheter accessories, insertion of drainage catheter kit, puncture and insertion system, snap lock drainage catheter set, ureteral catheter, propulsion tube, ureteral balloon dilation catheter, subcutaneous pyelostomy with ureteral catheterization, kidney transplantation ureteral catheter, tumor ureteral catheter, ureteroscopy applicable ureteral catheter, angle sleeve, and urinary tract stone removal products. In addition, it offers blood circuit tube parts, deodorizing and antibacterial spray, biliary balloon dilation catheter, nasobiliary drainage catheter, surgical drainage catheter, leg-binding urine bag, and drainage bag, as well as PVC IV infusion bags, PVC pipe bags, accessories for infusion bags, infusion extension tubing, and IV set. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Jin-Long Lin
  • Employees0
  • HeadquartersNo. 23 Chang-An East Road, Taipei, Taiwan, 104, Taiwan
  • Websitehttps://www.bioteq.com.tw/zh-tw

Leadership

  • Mr. Jin-Long LinGM, Senior VP & Director
  • Mr. Yi-Zhong HuangChief Financial Officer
  • Jia-Cheng WuMarketing and Product Manager
  • Mr. Yi-Xun LiVP & Director · b. 1971
  • Yu-Zheng WuHead of the Production Department

Financials

Income Statement

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue491.85M560.06M654.86M780.01M821.62M760.31M842.31M957.88M1.12B1.26B1.41B1.42B1.61B1.86B1.95B1.83B2.01B1.94B2.07B2.14B
Growth (%)-+13.87%+16.93%+19.11%+5.33%-7.46%+10.78%+13.72%+17.31%+12.08%+11.71%+0.94%+13.57%+15.24%+4.77%-6.27%+10.12%-3.26%+6.58%+3.03%
Cost of Revenue361.67M415.40M460.94M500.55M512.61M519.94M548.16M571.84M648.50M708.72M780.98M816.54M923.97M1.04B1.10B1.02B1.17B1.14B1.17B1.20B
Gross Profit130.18M144.66M193.93M279.46M309.01M240.38M294.14M386.05M475.17M550.70M625.98M603.67M689.04M816.96M851.75M802.87M844.54M805.35M905.08M936.93M
Gross Margin26.47%25.83%29.61%35.83%37.61%31.62%34.92%40.30%42.29%43.73%44.49%42.51%42.72%43.95%43.73%43.98%42.01%41.41%43.67%43.88%
Operating Expense80.23M94.09M108.62M124.06M134.39M134.56M139.22M149.58M176.85M182.48M187.28M175.50M199.85M222.45M248.54M262.77M217.04M225.17M261.91M266.66M
Operating Income49.95M50.57M85.30M155.40M174.62M105.82M154.93M236.47M298.32M368.22M438.70M428.17M489.19M594.50M603.21M540.09M627.50M580.18M643.17M670.28M
Operating Margin10.16%9.03%13.03%19.92%21.25%13.92%18.39%24.69%26.55%29.24%31.18%30.15%30.33%31.98%30.97%29.59%31.21%29.83%31.03%31.39%
EBITDA114.53M60.51M232.12M224.44M255.94M202.96M250.95M319.48M405.67M477.14M521.68M474.88M604.14M690.63M714.93M662.30M759.13M736.14M850.60M853.72M
EBITDA Margin23.29%10.80%35.44%28.77%31.15%26.69%29.79%33.35%36.10%37.89%37.08%33.44%37.45%37.15%36.71%36.28%37.76%37.85%41.04%39.98%
Net Income57.27M309.15M171.46M158.52M172.59M128.60M166.31M215.22M290.90M315.77M358.23M303.94M405.00M464.17M488.67M431.26M493.54M452.55M528.26M539.18M
Net Income Margin11.64%55.20%26.18%20.32%21.01%16.91%19.74%22.47%25.89%25.07%25.46%21.40%25.11%24.97%25.09%23.62%24.55%23.27%25.49%25.25%
R&D16.44M23.47M30.94M34.99M41.53M47.29M45.36M45.86M52.51M53.88M55.69M37.77M37.96M51.47M71.82M68.83M69.98M70.44M76.26M73.30M
R&D as % of Total Revenue3.34%4.19%4.72%4.49%5.05%6.22%5.39%4.79%4.67%4.28%3.96%2.66%2.35%2.77%3.69%3.77%3.48%3.62%3.68%3.43%
Interest Expense9.81M11.30M6.31M2.64M3.23M3.46M2.95M2.48M2.83M3.57M3.37M2.83M2.96M1.93M1.25M1.90M4.32M11.60M9.37M7.54M
Interest Expense % of Total Revenue1.99%2.02%0.96%0.34%0.39%0.46%0.35%0.26%0.25%0.28%0.24%0.20%0.18%0.10%0.06%0.10%0.21%0.60%0.45%0.35%

Balance Sheet

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.31B1.65B1.72B1.73B1.69B1.63B1.63B2.00B2.35B2.50B2.56B2.62B2.77B2.94B3.56B3.86B4.48B4.62B4.65B4.66B
Total Liabilities530.68M478.39M535.56M474.29M441.82M387.34M342.89M381.06M465.21M606.13M486.40M484.69M457.51M452.37M899.55M1.06B1.45B1.43B1.20B1.05B
Total Equity778.61M1.17B1.19B1.25B1.24B1.24B1.28B1.62B1.88B1.90B2.08B2.14B2.31B2.49B2.66B2.80B3.03B3.19B3.44B3.61B
Cash--358.29M371.14M316.43M340.72M319.04M750.93M840.22M906.33M818.97M916.85M926.60M1.05B1.19B872.61M1.02B1.35B1.24B1.16B
Total Debt439.72M230.16M186.60M261.90M252.65M224.85M164.56M175.39M222.52M310.11M168.81M205.09M108.89M66.92M395.24M473.83M872.61M894.74M--
Net Debt439.72M230.16M-171.69M-109.24M-63.78M-115.86M-154.49M-575.54M-617.69M-596.22M-650.16M-711.76M-817.71M-987.67M-798.33M-398.78M-144.69M-459.68M--

Cash Flow

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow77.47M159.77M277.23M174.32M185.39M148.43M183.44M270.44M368.71M385.43M380.63M336.51M460.41M623.41M634.51M469.25M644.58M669.40M702.62M664.20M
Investing Cash Flow----------82.96M-153.15M-51.81M-116.68M-145.73M-275.85M-552.77M-579.83M---
Financing Cash Flow141.28M-111.63M-190.51M-37.17M-174.40M-158.54M-171.95M110.01M-13.93M-240.07M-312.40M-180.30M-338.39M-343.86M-211.00M-232.65M68.77M-301.39M--
Capital Expenditure63.36M111.36M281.67M148.96M32.00M40.30M24.49M118.46M272.47M85.82M136.85M63.44M107.74M139.40M171.78M550.87M726.83M97.59M98.43M57.50M
Free Cash Flow14.11M48.40M-4.44M25.36M153.39M108.14M158.95M151.98M96.24M299.61M243.78M273.07M352.67M484.02M462.72M-81.63M-82.25M571.80M604.19M606.70M
Dividends Paid--114.00M91.20M156.55M140.90M117.42M125.24M150.80M179.81M180.18M207.90M242.54M277.19M277.19M277.19M311.84M311.84M311.84M346.49M
FCF to OCF18.21%30.30%-1.60%14.55%82.74%72.85%86.65%56.20%26.10%77.73%64.05%81.15%76.60%77.64%72.93%-17.39%-12.76%85.42%85.99%91.34%
Dividend Paid to FCF---2566.90%359.61%102.06%130.30%73.87%82.41%156.69%60.01%73.91%76.13%68.77%57.27%59.90%-339.59%-379.15%54.54%51.61%57.11%

Earnings

Report DateJul 15, 2010Oct 15, 2010Mar 22, 2012Oct 30, 2012Aug 13, 2013Nov 12, 2013May 14, 2014Aug 13, 2014Nov 11, 2014Feb 25, 2015May 14, 2015Aug 14, 2015Nov 15, 2015Feb 26, 2016May 13, 2016Aug 14, 2016Nov 8, 2016Mar 15, 2017May 12, 2017Aug 14, 2017Nov 13, 2017Mar 22, 2018May 11, 2018Aug 13, 2018Nov 12, 2018Mar 21, 2019May 7, 2019Aug 14, 2019Nov 12, 2019Mar 17, 2020May 12, 2020Aug 11, 2020Nov 12, 2020Mar 16, 2021May 6, 2021Aug 12, 2021Nov 11, 2021Mar 10, 2022May 13, 2022Aug 12, 2022Nov 11, 2022Mar 9, 2023May 12, 2023Aug 11, 2023Nov 9, 2023Mar 12, 2024Aug 13, 2025Nov 10, 2025Aug 13, 2026
EPS Estimate0.770.871.010.690.620.960.901.011.001.091.111.161.291.271.191.391.241.411.491.641.271.291.371.561.631.571.511.711.871.871.791.641.971.891.861.882.06--1.691.861.921.421.751.942.051.881.982.16
EPS Actual0.840.740.390.700.430.920.901.051.091.091.021.111.440.961.311.451.161.210.691.031.331.321.191.631.351.641.671.891.641.481.571.561.752.171.731.311.291.871.751.791.931.641.421.482.101.511.621.972.19
Surprise9.09%-14.94%-61.39%1.45%-30.65%-4.17%0.00%3.96%9.00%0.00%-8.11%-4.31%11.63%-24.41%10.08%4.32%-6.45%-14.18%-53.69%-37.20%4.72%2.33%-13.14%4.49%-17.18%4.46%10.60%10.53%-12.30%-20.86%-12.29%-4.88%-11.17%14.81%-6.99%-30.32%-37.38%--5.92%3.76%-14.58%0.00%-15.43%8.25%-26.34%-13.83%-0.51%1.39%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap7.62B
Enterprise Value6.29B
Trailing P/E13.00
Forward P/E23.42
Price / Sales3.43
Price / Book2.17
EPS8.46
Book Value50.91
Revenue (TTM)2.22B
Gross Profit (TTM)1.00B
EBITDA877.04M
Profit Margin26.54%
Operating Margin33.35%
Return on Equity17.29%
Return on Assets9.36%
Shares Outstanding69.30M
Shares Float47.56M
Beta0.12
Dividend Yield5.00%
Dividend Rate5.50
Payout Ratio132.21%

Dividends

20261×
5.50Jul 28, 2026
20251×
5.00Jul 28, 2025
20241×
4.50Jul 30, 2024
20231×
4.50Aug 30, 2023
20221×
4.50Aug 31, 2022
20211×
4.00Aug 31, 2021
20201×
4.00Aug 26, 2020
20191×
4.00Aug 29, 2019
20181×
3.50Aug 30, 2018
20171×
2.00Aug 29, 2017
20161×
2.60Aug 25, 2016
20151×
2.61Sep 24, 2015
20141×
1.77Aug 28, 2014
20131×
1.58Aug 28, 2013
20121×
1.48Aug 28, 2012
20111×
1.78Aug 26, 2011
20101×
1.97Sep 2, 2010
20091×
1.18Aug 24, 2009
20081×
1.44Sep 12, 2008

Stock Splits

  • Aug 24, 2009103:100